Elmer Piros
Analyst (Lucid Capital Markets)
Analyst — Lucid Capital Markets
Earnings-call appearances
-
Inmune Bio, Inc. Q4 FY2025 Earnings Call2025-12-31
Inmune Bio, Inc. (INMB)
-
Conference call to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL5012025-08-27
BioXcel Therapeutics, Inc. (BTAI)